Bronchopulmonary dysplasia is a chronic respiratory disease that results from complications related to lung injury during the treatment of infant acute respiratory distress syndrome in low-birth-weigh...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
The documentation surrounding bronchopulmonary dysplasia is limited due to its complex nature and the fact that it primarily affects a small population of premature infants. This rarity makes it challenging to conduct large-scale clinical studies. Additionally, the clinical features can vary significantly among affected individuals, complicating systematic characterization.
To navigate bronchopulmonary dysplasia, consider consulting a pediatric pulmonologist who specializes in respiratory diseases in infants and children. Engaging with a genetic counselor may also provide insights, especially if there are concerns about familial patterns or genetic predispositions. Although there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center at https://rarediseases.info.nih.gov. Participating in clinical trials may also offer access to emerging therapies.
There are several orphan drugs in development for bronchopulmonary dysplasia, including allogeneic umbilical cord-derived mesenchymal stem cell therapies and recombinant human surfactant protein-D. Currently, there are 79 active clinical trials investigating various treatment options and interventions for BPD. For more information on these trials, you can visit the ClinicalTrials.gov search page at https://clinicaltrials.gov/search?cond=bronchopulmonary%20dysplasia.
Actionable guidance for navigating care for bronchopulmonary dysplasia
To navigate bronchopulmonary dysplasia, consider consulting a pediatric pulmonologist who specializes in respiratory diseases in infants and children. Engaging with a genetic counselor may also provide insights, especially if there are concerns about familial patterns or genetic predispositions. Although there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center at https://rarediseases.info.nih.gov. Participating in clinical trials may also offer access to emerging therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Advent Therapeutics, Inc.
Other
Airway Therapeutics LLC
Other
Arriva Pharmaceuticals, Inc.
Other
AyuVis Research, Inc.
Other
Exo Biologics SA
Other
Fox Pharma, Inc.
Other
Insmed Incorporated
Other
Iorek Pharma Limited
Other
LABORATOIRE AGUETTANT
Other
Lee’s Pharmaceutical (HK) Limited
Other
MEDIPOST America, Inc.
Other
Meribank Biotech Co. Ltd.
Other
OHB Neonatology Ltd
Other
Orphanix GmbH
Other
Savient Pharmaceuticals, Inc.
Other
Stella Kourembanas, M.D.
Other
Synergen, Inc.
Other
Trimunocor Ltd.
Other